Therapeutic mechanism of Compound Xuanju Capsule on erectile dysfunction.
- Author:
Zi-Jie LI
1
;
Hao-Xiang XU
1
;
Wei WANG
1
;
Yue YANG
1
;
Cheng-Lin YANG
1
;
Zhi CAO
1
;
Xiao-Ming ZHANG
1
Author Information
1. Department of Urology, General Hospital of Southern Theater Command, Guangzhou, Guangdong 510010, China.
- Publication Type:Journal Article
- Keywords:
erectile dysfunction； Compound Xuanju Capsule； network pharmacology； molecular docking； anti-oxidation
- MeSH:
Drugs, Chinese Herbal/therapeutic use*;
Erectile Dysfunction/drug therapy*;
Molecular Docking Simulation;
Male;
Humans;
Signal Transduction;
Protein Interaction Maps;
Network Pharmacology;
Capsules;
Medicine, Chinese Traditional
- From:
National Journal of Andrology
2025;31(8):675-683
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the pharmacological mechanism of Compound Xuanju Capsule in the treatment of erectile dysfunction (ED) by using network pharmacology and molecular docking technology.
METHODS:The active ingredients and targets of Compound Xuanju Capsule were screened using Traditional Chinese Medicine Systematic Pharmacology Database and Analysis Platform (TCMSP). TTD, OMIM, DrugBank and GeneCards databases were used to obtain genes related to ED, and the union of the results was taken as the disease genes of ED. The common target of drug and disease was taken as the potential target of Compound Xuanju Capsule in ED, and the drug-disease interaction network was constructed by using Cytoscape software. The protein-protein interaction (PPI) network was constructed by using String database, which was then imported into Cytoscape to identify the key target. Based on the drug-disease intersection genes, GO and KEGG enrichment analyses were performed to predict the relevant signaling pathways and molecular mechanisms of Compound Xuanju Capsule for the treatment of ED. Autodock software was used to perform molecular docking between the active ingredients and the core targets.
RESULTS:Forty chemical components of Compound Xuanju Capsule were screened, and 239 predicted targets were obtained. A total of 1 907 ED-related genes were screened, and 97 common targets were identified between Compound Xuanju Capsule and ED, among which the core targets included EGFR, ESR1, HIF1A, PTGS2, and STAT3. The signaling pathways obtained by KEGG enrichment analysis included calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, cGMP-PKG signaling pathway, relaxin signaling pathway, Serotonergic synapse signaling pathway. The molecular docking results showed that there were molecular binding sites between the key active ingredients and the core targets with strong binding activity.
CONCLUSION:Compound Xuanju Capsule may treat ED through multi-target pathways such as anti-inflammatory and improving cellular oxidative stress.
